梅斯医学与浪潮健康达成战略合作

2021-04-23 梅斯市场发布 MedSci原创

梅斯医学与浪潮签署战略合作协议

4月23日,梅斯医学与浪潮健康于第五届RWE真实世界研究峰会上达成战略合作,浪潮健康副总经理潘湘国,梅斯医学副总经理王帅出席签约仪式,代表双方签署战略合作协议。

战略合作协议签约仪式现场

梅斯医学副总经理王帅表示:“双方将本着友好合作、互利互惠、共同发展的原则,协商一致,共同达成真实世界研究服务、基于医疗数据的创新产品探索等战略合作。双方将依托各自优势资源及双赢、可持续发展的战略伙伴关系,整合医药卫生行业数据需求,共同开展药械科研、临床研究、市场洞察等业务合作。”

梅斯医学副总经理王帅

浪潮健康副总经理潘湘国在致辞中表示:“高质量、适用的RWD 是产生RWE 的基础。浪潮健康在各地政府和卫健委的官方授权下,平台已经汇聚了覆盖700多家医疗机构(100多家三级医院),6000多万人口的全生命周期的真实世界数据。数据采集治理方面,浪潮健康采用国际先进标准,建立患者主索引,打破数据孤岛,实现患者跨院数据互联互通,形成患者360度数据全景视图。RWE的产生亦离不开科学的试验方案,严谨的数据分析,专业的医学转化,我们非常高兴可以与业界翘楚梅斯医学全面开启战略合作。相信通过RWD+RWS,双方一定会为创新药物源源不断地产生医学证据RWE,充分发掘药械产品的价值,最终使患者和更广大人群受益。”

浪潮健康副总经理潘湘国

基于此合作,浪潮健康作为全国多省市健康医疗大数据平台建设运营方,依托海量真实世界数据资源及智能数据治理,梅斯医学发挥真实世界研究等临床医学科研服务的优势,共同探索健康医疗大数据在临床科研、药械上市后研究、市场洞察等方向的应用与创新。

具体说来,基于真实世界数据,可进行卫生经济学评价、产品适应症拓展、经典名方和院内制剂的临床研究、流行病学研究、安全有效性研究、患者依从性研究、疾病风险预测模型、患者流分析、区域处方分析报告等相关研究及服务,助力药械企业与科研机构发展,为医生和科研人员工作提供便利,最终使患者和更广大人群受益。

第五届RWE真实世界研究峰会现场

关于梅斯医学:

梅斯医学(MedSci)是面向医生的综合互联网平台,应用大数据和人工智能技术链接医生、患者、药械企业等,提供精准数字化医学传播解决方案,优化医疗生态,改善医疗质量,共创美好健康生活。

梅斯医学主要产品包括数字化医学传播和数字化临床研究,涵盖临床研究、医生职业成长、多渠道学术传播、智慧医疗等类别。在数字化临床研究层面,提供临床研究整体解决方案,通过数字化技术降低成本,提升质量;在数字化医学传播方面,提供数字化的专业医学内容和精准、整合的传播方案,将最新的技术与知识精准地传递给目标医生。

同时,梅斯积极在患者管理、药物经济学等领域不断拓展新的业务类型和创新的产品。

 

关于浪潮健康

浪潮集团是中国领先的云计算和大数据服务高科技企业,拥有浪潮信息、浪潮软件、浪潮国际三家上市公司,为全球170多个国家和地区提供IT产品和运营服务,是中国最大的政府云服务和独立应用软件服务供应商。

浪潮健康是浪潮集团下属子公司,是国内领先的健康医疗大数据平台服务运营商,依托自主研发健康医疗大数据HDSP平台,以及领先的大数据标准、成熟的服务运营体系和“平台+生态”合作发展模式,已经与济南、天津、内蒙古、南宁等省市政府战略合作,形成全国布局。

在政府授权和数据安全合规前提下,形成服务于科研的专病数据队列,为医药企业、临床专家、生态合作企业提供基于区域数据平台的真实世界研究服务,助力药物经济学研究、流行病学研究、患者诊疗模式与疾病负担研究、市场洞察等项目的开展和数据分析。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1277191, encodeId=657012e719114, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478274, encodeId=ba6d14e827487, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959964, encodeId=392395996470, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=tjlyp, createdTime=Sat Apr 24 09:19:44 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959950, encodeId=e3c795995025, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367f5485585, createdName=ms4000002020660881, createdTime=Sat Apr 24 08:45:53 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959842, encodeId=2ae4959842da, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:13:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959828, encodeId=ca3e9598282d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Apr 23 17:58:51 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-25 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1277191, encodeId=657012e719114, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478274, encodeId=ba6d14e827487, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959964, encodeId=392395996470, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=tjlyp, createdTime=Sat Apr 24 09:19:44 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959950, encodeId=e3c795995025, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367f5485585, createdName=ms4000002020660881, createdTime=Sat Apr 24 08:45:53 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959842, encodeId=2ae4959842da, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:13:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959828, encodeId=ca3e9598282d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Apr 23 17:58:51 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1277191, encodeId=657012e719114, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478274, encodeId=ba6d14e827487, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959964, encodeId=392395996470, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=tjlyp, createdTime=Sat Apr 24 09:19:44 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959950, encodeId=e3c795995025, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367f5485585, createdName=ms4000002020660881, createdTime=Sat Apr 24 08:45:53 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959842, encodeId=2ae4959842da, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:13:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959828, encodeId=ca3e9598282d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Apr 23 17:58:51 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-24 tjlyp

    感谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1277191, encodeId=657012e719114, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478274, encodeId=ba6d14e827487, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959964, encodeId=392395996470, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=tjlyp, createdTime=Sat Apr 24 09:19:44 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959950, encodeId=e3c795995025, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367f5485585, createdName=ms4000002020660881, createdTime=Sat Apr 24 08:45:53 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959842, encodeId=2ae4959842da, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:13:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959828, encodeId=ca3e9598282d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Apr 23 17:58:51 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-24 ms4000002020660881

    厉害

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1277191, encodeId=657012e719114, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478274, encodeId=ba6d14e827487, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959964, encodeId=392395996470, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=tjlyp, createdTime=Sat Apr 24 09:19:44 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959950, encodeId=e3c795995025, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367f5485585, createdName=ms4000002020660881, createdTime=Sat Apr 24 08:45:53 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959842, encodeId=2ae4959842da, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:13:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959828, encodeId=ca3e9598282d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Apr 23 17:58:51 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-23 jyzxjiangqin

    好文章!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1277191, encodeId=657012e719114, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478274, encodeId=ba6d14e827487, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Sun Apr 25 08:38:12 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959964, encodeId=392395996470, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=tjlyp, createdTime=Sat Apr 24 09:19:44 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959950, encodeId=e3c795995025, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367f5485585, createdName=ms4000002020660881, createdTime=Sat Apr 24 08:45:53 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959842, encodeId=2ae4959842da, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:13:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959828, encodeId=ca3e9598282d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Apr 23 17:58:51 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-23 医鸣惊人

    认真学习了

    0